Financial Year |
March 31 2023 |
Monetary Funds |
240,373,426.18 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
11,097,709.61 |
Advances to Suppliers |
3,014,582.82 |
Other Receivables |
6,605,136.76 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
107,830,751.05 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
55,967,383.21 |
Total Current Assets |
424,888,989.63 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
171,502,272.46 |
Investment Properties |
-- |
Fixed Assetes |
243,152,709.40 |
Under-construction Projects |
4,102,994.34 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
50,464,256.76 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
2,338,998.78 |
Deferred Income Tax Assets |
33,935,702.92 |
Other Non-Current Assets |
126,603.77 |
Sub-Total of Non-Current Assets |
513,898,504.19 |
Total Assets |
938,787,493.82 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
4,389,083.37 |
Accounts Payable |
16,025,736.77 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
5,960,280.17 |
Taxes Payable |
3,304,824.76 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
7,467,053.03 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,158,707.81 |
Other Current Liabilities |
1,833,054.21 |
Sub-Total of Current Liabilities |
55,514,260.02 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,558,638.30 |
Total Liabilities |
58,072,898.32 |
Paid-In Capital(Or Share Stock) |
354,025,000.00 |
Capital Surplus |
159,500,120.12 |
Surplus Reserve |
74,825,071.75 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
292,396,729.01 |
Minority Stockholder's Interest |
-32,325.38 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
880,746,920.88 |
Owner's Equity(Stockholder's Equity) |
880,714,595.50 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
938,787,493.82 |